(Q79714924)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Hiroyuki Higashiyama

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Daisuke Yoshimoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Toshihiko Kaise

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Shigeki Matsubara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Masatoshi Fujiwara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Hideo Kikkawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Satoshi Asano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Mine Kinoshita

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

24 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

Experimental and Molecular Pathology

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

39-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

Simple method of estimating severity of pulmonary fibrosis on a numerical scale

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

The role of transforming growth factor beta in lung development and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Pulmonary fibrosis: pathways are slowly coming into light

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Smad3 as a mediator of the fibrotic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Smads as intracellular mediators of airway inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

ALK5 inhibition in renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

TGF-beta signaling and the fibrotic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

CCN proteins: multifunctional signalling regulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

The myofibroblast in pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Mechanisms of pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF-beta signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.12.003

10.1016/J.YEXMP.2006.12.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274978%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference